PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis.

J Clin Med · 2020 · PMC7408884 · PMID 32635291

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

IMpower150 was the only study to include this type of patient, showing a positive trend in OS probably due to the addition of bevacizumab to the combination strategy, as previously discussed [ 43 ].

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.